Feature | Cath Lab | September 12, 2017

Cardiovascular Research Foundation Appointed Juan Granada as New President, CEO

Distinguished cardiologist takes the helm of key interventional cardiology organization, sponsor of TCT

Cardiovascular Research Foundation (CRF) announced the promotion of Juan F. Granada, M.D., as the foundation’s president and chief executive officer (CEO). CRF sponsors TCT.

The Cardiovascular Research Foundation (CRF) announced the promotion of Juan F. Granada, M.D., as the foundation’s president and chief executive officer (CEO).

September 12, 2017 – The Cardiovascular Research Foundation (CRF) announced the promotion of Juan F. Granada, M.D., as the foundation’s president and chief executive officer (CEO). Granada was also appointed to CRF’s Board of Directors. A renowned leader in cardiology, he joined CRF in 2007 and served as executive director and chief innovation officer at the CRF Skirball Center for Innovation. He is also an assistant professor of medicine at Columbia University College of Physicians and Surgeons. 

Granada also has served as a member of the Editorial Board for Diagnostic and Interventional Cardiology (DAIC) magazine since 2010.

“Juan’s proven leadership skills, along with his expertise across preclinical, clinical, and educational initiatives will help CRF strengthen and expand its role in the development of innovative new technologies and therapies that will benefit people with heart disease worldwide,” said Eric B. Woldenberg, Esq., chairman of the CRF Board of Directors and a senior partner at Pryor Cashman LLP.

“Since its inception, CRF has played a major role in the rapid progress that has been made in interventional cardiology by establishing the safe use of new technologies and therapies for heart disease,” Granada said. “I am eager to take on this new role and work with my distinguished colleagues to ignite the next wave of innovation that will help doctors save and improve the quality of their patients’ lives.”

“CRF has grown due to a special blend of passion, creativity, and productivity, and Juan embodies our innovative culture,” said Martin B. Leon, M.D., founder and chairman emeritus of CRF and its co-director, medical research and education. “With his unique combination of advanced interventional skills, entrepreneurial spirit, and business insight, he has the visionary capacity to foresee new opportunities. Importantly, Juan is a caring and thoughtful people person who will catalyze communication and collaboration both inside and outside the organization.”

“Juan’s professionalism, creativity and ‘can do’ mindset make him an exceptional individual for this position,” added Gregg W. Stone, M.D., CRF’s co-director of medical research and education. “His knowledge of interventional cardiovascular medicine from bench to bedside coupled with extensive expertise in medical innovation will propel CRF to new levels of achievement in research and education.”

Granada is one of the world’s foremost investigators in the translational validation of novel cardiovascular therapies. He has helped develop and successfully validate several endovascular imaging and device technologies. He received his medical degree from the Institute of Health Sciences in Medellin, Colombia and finished his cardiovascular disease and interventional cardiology fellowships at Baylor College of Medicine in Houston, Texas.  

 

Video and Article Interviews With Dr. Juan Granada:

VIDEO: Bioresorbable Stent Failure Modes, Technique, Patient Selection and Future Development

VIDEO: Transcatheter Mitral Valve Technology, Anatomical Challenges

Advances and Future Directions for Transcatheter Valves

VIDEO: Transcatheter Mitral Valve Therapies in Development — TVT 2015

VIDEO: The Evolution of TAVR Technology — TVT 2015

Transcatheter Mitral Valve Replacement Devices in Development

Drug-eluting Balloons Enter the U.S. Market

Advances in Intravascular Imaging

 

For more information: www.crf.org

Related Content

Amazon, Berkshire Hathaway and JPMorgan Chase to Form New Healthcare Company
News | Business | January 30, 2018
January 30, 2018 — Amazon , Berkshire Hathaway and JPMorgan Chase & Co.
News | Business | January 16, 2018
American College of Cardiology (ACC) Chief Executive Officer Shalom “Shal” Jacobovitz will be leaving the College...
CMS Launches New Voluntary Bundled Payments Model
News | Business | January 10, 2018
The Centers for Medicare & Medicaid Services (CMS) Center for Medicare and Medicaid Innovation (Innovation Center)...
Toshiba Medical Systems Changes Name to Canon Medical Systems Corp.
News | Business | January 08, 2018
January 8, 2018 — Canon Inc. and Canon Medical Systems Corp.
CMS Announces Final Changes, Cancellations of Mandatory Bundled Payment Models
News | Business | December 21, 2017
The Centers for Medicare & Medicaid Services (CMS) last week finalized the cancellation of the mandatory hip...
Catheter reprocessing can reduce costs in the cath and EP lab.
Feature | Business | December 19, 2017 | Lars Thording
As payers and other healthcare entities look to better manage costs, especially in the acute care setting, it is impo
FDA Issues Final Guidance on Investigational Device Exemption Categorization
News | Business | December 19, 2017
The U.S. Food and Drug Administration (FDA) recently issued a final guidance, “FDA Categorization of Investigational...
Congressional Budget Office Finds cutting ACA insurance mandate will cause 13 million people to become uninsured, higher insurance premiums. American Heart Association (AHA), #AHA2017
News | Business | December 06, 2017
December 6, 2017 — At the American Heart Association (AHA) annual meeting in November, a group of 16 non-partisan pat
5 Tips for Medical Device Engineers on FDA Design Controls
Feature | Business | November 24, 2017 | Jon Speer
If you are an engineer in the medical device industry, you probably have a love/hate relationship with the FDA-mandat
Videos | Business | November 09, 2017
A discussion with Peter L.
Overlay Init